{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:03:45Z","timestamp":1785557025612,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jchf.2025.03.042","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T05:02:21Z","timestamp":1749445341000},"page":"102498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-582X","authenticated-orcid":false,"given":"Mats C.H.","family":"Lassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-9414","authenticated-orcid":false,"given":"John W.","family":"Ostrominski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9276-8380","authenticated-orcid":false,"given":"Brendon L.","family":"Neuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Beldhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-4144","authenticated-orcid":false,"given":"Jawad Haider","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldrin F.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finnian","family":"Mc Causland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inder S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.03.042_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.03.042_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2025.03.042_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2025.03.042_bib4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jchf.2023.05.015","article-title":"Cardio-renal-metabolic overlap, outcomes, and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"11","author":"Ostrominski","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.03.042_bib5","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2025.03.042_bib6","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jchf.2018.08.007","article-title":"Pivotal role of excess intra-abdominal adipose in the pathogenesis of metabolic\/obese HFpEF","volume":"6","author":"Kitzman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.03.042_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41569-020-00465-5","article-title":"Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging","volume":"18","author":"Ng","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2025.03.042_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.03.042_bib9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/ajcn\/82.4.872","article-title":"Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study","volume":"82","author":"Newman","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jchf.2025.03.042_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41387-017-0012-y","article-title":"Associations between body mass index and the risk of renal events in patients with type 2 diabetes","volume":"8","author":"Mohammedi","year":"2018","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.jchf.2025.03.042_bib11","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1038\/s41598-018-24757-6","article-title":"Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jchf.2025.03.042_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000041","article-title":"High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease","volume":"93","author":"Huang","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 3","key":"10.1016\/j.jchf.2025.03.042_bib13","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/ijo.2008.87","article-title":"BMI-related errors in the measurement of obesity","volume":"32","author":"Rothman","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jchf.2025.03.042_bib14","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/oby.22574","article-title":"Estimated glomerular filtration rate bias in participants with severe obesity regardless of deindexation","volume":"27","author":"Guebre-Egziabher","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jchf.2025.03.042_bib15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2215\/CJN.02140214","article-title":"Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States","volume":"9","author":"Sharma","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2025.03.042_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/eurheartj\/ehad083","article-title":"Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox","volume":"44","author":"Butt","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.03.042_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010159","article-title":"Waist-to-height ratio as an indicator of \u201cearly health risk\u201d: simpler and more predictive than using a \u201cmatrix\u201d based on BMI and waist circumference","volume":"6","author":"Ashwell","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jchf.2025.03.042_bib18","series-title":"Overview, Obesity: identification, assessment and management, Guidance","year":"2014"},{"key":"10.1016\/j.jchf.2025.03.042_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib21","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib24","series-title":"Recommendations, Obesity: identification, assessment and management, Guidance","year":"2014"},{"key":"10.1016\/j.jchf.2025.03.042_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.03.042_bib27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ejhf.1050","article-title":"Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion","volume":"20","author":"Van Aelst","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.03.042_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jchf.2021.12.005","article-title":"Renal compression in heart failure: the renal tamponade hypothesis","volume":"10","author":"Boorsma","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.03.042_bib29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfq522","article-title":"Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients","volume":"26","author":"Lamacchia","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jchf.2025.03.042_bib30","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/jch.13366","article-title":"Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients","volume":"20","author":"Geraci","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jchf.2025.03.042_bib31","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11255-013-0404-4","article-title":"Sonographic evaluation of para- and perirenal fat thickness is an independent predictor of early kidney damage in obese patients","volume":"45","author":"Sun","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jchf.2025.03.042_bib32","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ejhf.1956","article-title":"Regional adiposity and heart failure with preserved ejection fraction","volume":"22","author":"Rao","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.03.042_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","article-title":"Functional and structural changes in the kidney in the early stages of obesity","volume":"12","author":"Henegar","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2025.03.042_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2025.03.042_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/j.ajkd.2015.10.025","article-title":"Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study","volume":"67","author":"Melsom","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2025.03.042_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2025.03.042_bib37","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2025.03.042_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.ajkd.2008.03.003","article-title":"Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study","volume":"52","author":"Foster","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2025.03.042_bib39","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.2337\/dc08-0971","article-title":"Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry","volume":"31","author":"Luk","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2025.03.042_bib40","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.03.042_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00392-018-1302-7","article-title":"Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose-response meta-analysis","volume":"108","author":"Zhang","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jchf.2025.03.042_bib42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ijo.2013.203","article-title":"The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data","volume":"38","author":"Padwal","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jchf.2025.03.042_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9040248","article-title":"The obesity paradox and heart failure: a systematic review of a decade of evidence","volume":"2016","author":"Oga","year":"2016","journal-title":"J Obes"},{"key":"10.1016\/j.jchf.2025.03.042_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(14)70156-1","article-title":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2025.03.042_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0420","article-title":"Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial","volume":"155","author":"Cohen","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jchf.2025.03.042_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2025.03.042_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.03.042_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib49","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(18)30268-7","article-title":"Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial","volume":"6","author":"Muskiet","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2025.03.042_bib51","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib52","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.03.042_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925004251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925004251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:21:51Z","timestamp":1785554511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925004251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213177925004251"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.03.042","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}],"article-number":"102498"}}